139 related articles for article (PubMed ID: 33092467)
1. Improving sensitivity of the connective tissue disease screening questionnaire: A comparative study of various scoring methods.
Xiang L; Low AHL; Leung YY; Fong W; Gandhi M; Xin X; Uy EJ; Sparks JA; Karlson EW; Thumboo J
Lupus; 2021 Jan; 30(1):35-44. PubMed ID: 33092467
[TBL] [Abstract][Full Text] [Related]
2. Cross-cultural adaptation of the connective tissue disease screening questionnaire and development of a Chinese version in a multi-ethnic Asian population.
Xiang L; Teo EPS; Low AHL; Leung YY; Fong W; Xin X; Gandhi M; Kwan YH; Uy EJB; Sparks JA; Karlson EW; Thumboo J
Clin Rheumatol; 2019 Sep; 38(9):2383-2397. PubMed ID: 31037459
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of systemic lupus erythematosus-related symptoms assessed by using the Connective Tissue Disease Screening Questionnaire in a large population-based cohort.
Lambers W; Arends S; Roozendaal C; Brouwer E; Bootsma H; Westra J; de Leeuw K
Lupus Sci Med; 2021 Nov; 8(1):. PubMed ID: 34795031
[TBL] [Abstract][Full Text] [Related]
4. Implementation of the Connective Tissue Screening Questionnaire in northeast Pennsylvania to identify comorbidities of connective tissue diseases in subjects with systemic lupus erythematosus.
Farrell MS; Wallace SJ; Clarke SM; Tarafder MR; McLaughlin WA
J Prim Care Community Health; 2014 Apr; 5(2):134-8. PubMed ID: 24327597
[TBL] [Abstract][Full Text] [Related]
5. A Korean rheumatic diseases screening questionnaire.
Lee HS; Oh KT; Kim TH; Jung S; Yoo DH; Bae SC
J Korean Med Sci; 2003 Apr; 18(2):171-8. PubMed ID: 12692412
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy.
Spinillo A; Beneventi F; Ramoni V; Caporali R; Locatelli E; Simonetta M; Cavagnoli C; Alpini C; Albonico G; Prisco E; Montecucco C
Ann Rheum Dis; 2012 Jun; 71(6):918-23. PubMed ID: 22294629
[TBL] [Abstract][Full Text] [Related]
7. The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study.
Spinillo A; Beneventi F; Locatelli E; Ramoni V; Caporali R; Alpini C; Albonico G; Cavagnoli C; Montecucco C
BMC Pregnancy Childbirth; 2016 Oct; 16(1):313. PubMed ID: 27756248
[TBL] [Abstract][Full Text] [Related]
8. Overlap syndromes.
Fiori G; Pignone A; Cerinic MM
Reumatizam; 2002; 49(2):12-5. PubMed ID: 12476753
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary hypertension in autoimmune rheumatic diseases].
Marasini B; Massarotti M; Cossutta R; Massironi L; Mantero A
Reumatismo; 2005; 57(2):114-8. PubMed ID: 15983635
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
[TBL] [Abstract][Full Text] [Related]
11. [The classification and diagnosis of rheumatic diseases].
Ivashkin VT; Ermolina LM; Tiurin VP; Sultanov VK
Voen Med Zh; 1991 Apr; (4):50-4. PubMed ID: 1887610
[No Abstract] [Full Text] [Related]
12. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
13. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
Bossuyt X; De Langhe E; Borghi MO; Meroni PL
Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
[TBL] [Abstract][Full Text] [Related]
14. Development, Sensibility, and Validity of a Systemic Autoimmune Rheumatic Disease Case Ascertainment Tool.
Armstrong SM; Wither JE; Borowoy AM; Landolt-Marticorena C; Davis AM; Johnson SR
J Rheumatol; 2017 Jan; 44(1):18-23. PubMed ID: 27803141
[TBL] [Abstract][Full Text] [Related]
15. The association of malignancy with rheumatic and connective tissue diseases.
Carsons S
Semin Oncol; 1997 Jun; 24(3):360-72. PubMed ID: 9208890
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women.
Karlson EW; Costenbader KH; McAlindon TE; Massarotti EM; Fitzgerald LM; Jajoo R; Husni E; Wright EA; Pankey H; Fraser PA
Lupus; 2005; 14(10):832-6. PubMed ID: 16304727
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases.
Jeong S; Yang H; Hwang H
PLoS One; 2017; 12(3):e0173597. PubMed ID: 28273146
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.
Atzeni F; Gerardi MC; Barilaro G; Masala IF; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2018 Jan; 14(1):69-82. PubMed ID: 29202589
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of autoimmune rheumatic diseases.
Goldblatt F; O'Neill SG
Lancet; 2013 Aug; 382(9894):797-808. PubMed ID: 23993190
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of connective tissue disorders.
Gaubitz M
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii3-4. PubMed ID: 16987829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
